The Sarah Cannon Research Institute was established
In 2004, the Sarah Cannon Research Institute was formed to bring together community-based physicians, researchers and clinicians to…
-
-
A clinical trial found post-menopausal survivors of early-stage breast cancer who took letrozole reduced risk of cancer recurrence
On Oct. 9, 2003, a Canadian-led international clinical trial found that post-menopausal survivors of early-stage breast cancer who…
-
Taking daily aspirin for as little as 3 years was shown to reduce the development of colorectal polyps
On Mar. 5, 2003, taking daily aspirin for as little as 3 years was shown to reduce the…
-
China granted the world’s first regulatory approval of a gene therapy product
In 2003, China granted the world’s first regulatory approval of a gene therapy product, Gendicine (Shenzhen SiBiono GenTech),…
-
The drug imatinib mesylate (Gleevec) was shown to be effective against chronic myelogenous leukemia
In 2001, the drug imatinib mesylate (Gleevec) was shown in a clinical trial to be effective against chronic…
-
Compulsive shopping research at Stanford seeks to treat mysterious disorder
On Dec. 16, 2002, researchers at Stanford University Medical Center announced they were continuing a multi-year clinical trial…
-
Biotechnology | Diagnostics | Disease | NIH | Oncology | Rare Disease | Therapeutics
The Stephenson Cancer Center was established
In 2001, the Stephenson Cancer Center was established. Located on the University of Oklahoma (OU) Health Sciences Center…
-
Biotechnology | Clinical Research | Disease | Medicine | NIH | Pharmaceutical | Therapeutics | Women's Health
President Clinton directed Medicare program to reimburse providers for cost of routine patient care in clinical trials
On Jun. 7, 2000, President Bill Clinton issued an Executive Memorandum that directed the Medicare program to revise…
-
A $60 million program was announced to address the unequal burden of cancer within certain special populations in the US
On Apr. 6, 2000, a $60 million program was announced to address the unequal burden of cancer within…
-
Biotechnology | FDA | Vaccine
Rabies vaccine (RabAvert by Chiron Behring) was licensed
On Oct. 20, 1997, the Food and Drug Administration (FDA) licensed a new rabies vaccine for both pre-exposure…
-
Penn Medicine’s Cancer Center was renamed the Abramson Cancer Center of the University of Pennsylvania
In 1997, the Penn Medicine’s Cancer Center was renamed the Abramson Cancer Center of the University of Pennsylvania…
-
Bristol-Myers Squibb launched TAXOL (paclitaxel)
In 1993, Bristol-Myers Squibb launched TAXOL (paclitaxel). The company invested hundreds of millions of dollars to supply TAXOL…
-
Biotechnology | Disease | NIH | Therapeutics
First human gene therapy trial was conducted
On Sept. 14, 1990, W. French Anderson and his colleagues at the National Institutes of Health (NIH) performed…
-
BOTOX(R) cosmetic (onabotulinumtoxinA) approved by the FDA
On Dec. 29, 1989, the U.S. Food and Drug Administration (FDA) approved Oculinum’s (onabotulinumtoxinA) for treatment of strabismus…
-
H. Stewart Parker founded Targeted Genetics Corp. in Seattle
On Jan. 1, 1989, Targeted Genetics, an Immunex Corp. spin-off in Seattle. which specialized in gene therapy, a…
-
Biotechnology | CRISPR | Diagnostics | Disease | NIH | Therapeutics
Dr. Marilyn Hughes Gaston published groundbreaking study that led to a national sickle cell disease screening program
In 1986, Dr. Marilyn Hughes Gaston while deputy branch chief of the Sickle Cell Disease Branch at the…
-
First clinical tests conducted at UW of EPO to correct anemia of kidney failure
In Dec. 1985, the first clinical tests were held at the University of Washington of erythropoietin (EPO), the…
-
The National Cancer Institute launched the Community Clinical Oncology Program
On Jul. 16, 1983, the National Cancer Institute launched the Community Clinical Oncology Program (CCOP) to provide a…
-
Biotechnology | Diagnostics | Disease | NIH
The Division of Resources, Centers and Community Activities was renamed the Division of Cancer Prevention and Control
In 1983, the National Cancer Institute’s Division of Resources, Centers and Community Activities was renamed the Division of…
-
Community Clinical Oncology Program was created
In 1983, the Community Clinical Oncology Program, an National Cancer Institute (NCI) resource that links community-based physicians with…
-
A new Biological Response Modifiers Program was established in the Division of Cancer Treatment
On Apr. 27, 1981, a new Biological Response Modifiers Program was established in the Division of Cancer Treatment…
-
The first human testing of a biological therapy was conducted (alpha-interferon)
On Nov. 9, 1978, the first human testing of a biological therapy was conducted (alpha-interferon). The Cancer Research…
-
Ontario researchers demonstrated that Aspirin can prevent strokes
On Jul. 13, 1978, Ontario researchers published the results of a study led by Dr. Henry Barnett that demonstrated…
-
National Cancer Institute established the first electronic registry of cancer clinical trials (CLINPROT)
In 1977, the National Cancer Institute (NCI) established the first electronic registry of cancer clinical trials (CLINPROT). This…
-
The U.S. FDA Bioresearch Monitoring Program was introduced
In 1977, the U.S. Food and Drug Administration (FDA) established the Bioresearch Monitoring Program (BiMo) to develop cross-center…
-
The Ohio State University Cancer Center received NCI comprehensive center designation
In 1976, the Ohio State University Cancer Center (OSUCCC) received National Cancer Institute (NCI) comprehensive center designation. The…
-
The Norris Comprehensive Cancer Center was founded
In 1973, the Norris Comprehensive Cancer Center, now the University of Southern California Kenneth Norris Jr. Cancer Center…
-
Biology | Diagnostics | Life Science History | NIH | Oncology | Radiology | Therapeutics
The Norris Cancer Center was designated NCI Comprehensive Cancer Center
In 1973, the Norris Cancer Center was designated a National Cancer Institute (NCI) Comprehensive Cancer Center, one of…
-
Biology | Diagnostics | Disease | Life Science History | Non-Profit Research | Oncology | Therapeutics
Cisplatin, a platinum-containing anticancer compound with unique biologic effects, entered clinical trials
In 1970, Cisplatin, a platinum-containing anticancer compound with unique biologic effects, entered clinical trials. On Dec. 19, 1978,…
-
Calvin Stiller conducted one of the first clinical trials studying the immunosuppressive drug cyclosporin for kidney transplants
In 1970, Dr. Calvin Stiller conducted one of the first clinical trials studying the effectiveness of the immunosuppressive…
